IN8BIO, INC. Notes and Loans Payable
IN8BIO, INC. (INAB) had Notes and Loans Payable of $174.00 thousand as of 2021-06-30, per its 10-Q filed 2021-09-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:NotesAndLoansPayable · last filed 2021-09-10
- 2021-06-30: Notes and Loans Payable $174.00K.
- 2020-12-31: Notes and Loans Payable $174.00K.
| Period end | Notes and Loans Payable |
|---|---|
| 2021-06-30 | $174.00K 10-Q · filed 2021-09-10 |
| 2020-12-31 | $174.00K 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |